NUZ 6.25% 22.5¢ neurizon therapeutics limited

Ann: Appendix 4C & Company Update - Sep 2018, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 148 Posts.
    lightbulb Created with Sketch. 39
    Talk about misleading, don't know which slide to go for... try the last:

    1. 'Approval in Canines for larger trials' - what approval? Has NOT been approved in Canines
    2. 'The Pivotal Trial for moving forward: Cancer Control' Pivotal - says who? It's controlling Cancer now!?
    3. Second Half of 2019 - chronologically must come AFTER mid 2019 - how is said event possible before!?
    4. Assuming somehow it is before (as it reads) 'Canine Cancer - Disease Free Interval and Long Term Survival'... Since when has that ever actually happened? how could they claim that!?
    5. Potential date for exercise option - what option? Ashton's share options?
    6. RETURN TO HUMAN TRIALS FOLLOWING DATA FROM CANINES AND EXPLORE FAST TRACK REGISTRATION!!! Don't need to submission and approval to start a human trial first? Don't need multiple animal species and a full pharm-tox package not just dog? Don't need Fast Track Designation BEFORE even consideration of a Fast Track Registration!!?

    Most importantly, these are just start dates of made up events - how long until any results let alone a return?
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.